Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) [Phase 2]
The CAPTUR Phase 2 trial by the Canadian Cancer Trials Group is currently recruiting and evaluates profiling and targeted agent utilization …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
This clinical trial update describes an ongoing prospective evaluation of delayed effects after pediatric CAR T cell therapy in acute lympho…
-
CLINICAL_TRIALS other · 2026-03-27Clinical Trial Update: Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib [Phase 1]
Phase 1 modular pharmacology study to evaluate drug-drug interaction potential and relative bioavailability of Saruparib; status is active b…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options [Phase 1, Phase 2]
Ongoing pediatric study of entrectinib (Rxdx-101) for locally advanced or metastatic solid tumors and/or primary CNS tumors with no satisfac…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors [Phase 1]
A Phase 1 clinical trial to evaluate VG2062 in patients with solid tumors is currently recruiting, assessing safety, tolerability, pharmacok…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) [Phase 2]
A Phase 2 trial evaluating BMS-986504 as monotherapy and in combination for MTAP-deleted advanced or metastatic solid tumors; the study is n…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans [NA]
A clinical trial update reports the completion of a bioequivalence study evaluating Trifluridine and Tipiracil hydrochloride tablets under f…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is an update on an ongoing Phase 1/2a first-in-human study of BMS-986517 in adults with advanced solid tumors; the trial is currently r…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: First In Human Study of CX-801 in Advanced Solid Tumors [Phase 1]
This update announces the first-in-human Phase 1 study of CX-801 for adults with advanced solid tumors, currently recruiting to assess safet…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors [Phase 1]
This clinical trial update announces the first-in-human Phase 1 study of GSK4381562 in participants with advanced solid tumors; the trial st…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a first-in-human study of IMP1734, a PARP1 selective inhibitor, in participants with advanced solid tum…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors [Phase 1]
A Phase 1 study evaluating GK01 Injection in adults with advanced malignant solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update for a Phase 1-2 study of ASTX660 in subjects with advanced solid tumors and lymphomas; recruitment status is ACTIVE_NO…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial update for DS-1055a in relapsed or refractory locally advanced or metastatic solid tumors; the study is currently a…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies [Phase 4]
Phase 4 trial evaluating olutasidenib for drug-drug interaction in IDH1-mutant malignancies. The study is currently recruiting in AML, gliom…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1) [Phase 2]
A Phase 2 MATCH subprotocol evaluating crizotinib for cancers with MET genetic alterations; results have been posted for this study.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor [Phase 1]
Phase 1 study to assess the safety, tolerability, and pharmacokinetics of ABSK-021 in patients with advanced solid tumors. The study include…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors [Phase 1]
A Phase 1 clinical trial is evaluating expanded multi-antigen specific lymphocytes for solid tumors. The trial is actively not recruiting an…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of CHS-114 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating CHS-114 in participants with advanced solid tumors, including head and neck squamous cell carcinoma; currently recr…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology [NA]
A clinical trial update describes a study on nurse-initiated conversations to support early integration of palliative care in pediatric onco…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors [Phase 1]
A Phase 1 trial of Azenosertib (ZN-c3) in participants with solid tumors has completed.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification [Phase 1]
BeiGene is conducting a first-in-human Phase 1 study of BGB-53038, a pan-KRAS inhibitor, as a monotherapy or in combination, in participants…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors [Phase 1]
A first-in-human Phase 1 study to evaluate the safety and tolerability of VVD-130037 in participants with advanced solid tumors. The trial i…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor [Phase 1]
Phase I study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of HLX97, a KAT6A/B inhibitor, in patients with adv…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]
Roche is conducting a dose-escalation Phase 1/2 trial of a PD-1/LAG-3 bispecific antibody in patients with advanced or metastatic solid tumo…